References
- BHIVA. 2005. British HIV Association guidelines. The management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. London: British HIV Association.
- Briand N, Mandelbrot L, Blanche S, Tubiana R, Faye A, Dollfus C .; for the ANRS French Perinatal Cohort (ANRS EPF-CO1). 2011. Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy. Journal of Acquired Immune Deficiency Syndromes 57:126–135.
- Briand N, Mandelbrot L, Le Chenadec J, Tubiana R, Teglas JP, Faye A .; ANRS French Perinatal Cohort. 2009. No relation between in-utero exposure to HAART and intrauterine growth retardation. AIDS 23:1235–1243.
- Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ . 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331:1173–1180.
- Johri M, Ako-Arrey D. 2011. The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review. Cost Effectiveness and Resource Allocation 9:3.
- , Kesho Bora Study Groupde Vincenzi I. 2011. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infectious Diseases 11:171–180.
- Shah M, Johns B, Abimiku A, Walker DG. 2011. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in Nigeria. AIDS 25:1093–1102.
- Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, Culnane M . 1998. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 12:1805–1813.
- Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C . and the French Perinatal Cohort. 2008. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 22:289–299.
- Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L . 2011. Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. Journal of Perinatal Medicine 39:163–170.